Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D6EI9F
|
|||
| Drug Name |
NEXI-002
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Phase 1/2 | [1] | |
| Company |
NexImmune
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04505813) Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.